HCM Hutchison China Meditech ADRs

Hutchison China Meditech Ltd is a major drug manufacturing company. The company operates two platforms--an innovation platform and a commercial platform aimed at discovering and developing therapeutics in oncology and autoimmune diseases. This is an ADR of a company whose stock trades outside of the U.S. as the symbol LN:HCM.

$31.66  -0.40 (-1.25%)
As of 10/26/2021 15:59:55 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  ADRs
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  China
Country of incorporation:  Cayman Islands
IPO date:  03/16/2016
Outstanding shares:  172,883,456
Average volume:  134,016
Market cap:   $5,561,660,780
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
CUSIP:    44842L103
ISIN:        US44842L1035
Sedol:      BYXV9H7

---

Valuation   (See tab for details)

---

PE ratio:   -33.54
PB ratio:   5.47
PS ratio:   20.50
Return on equity:   -16.30%
Net income %:   -60.90%